Clinical Highlights

Efficacy and Safety of a New Resilient Hyaluronic Acid Filler in the Correction of Moderate-to-Severe Dynamic Perioral Rhytides: A 52-Week Prospective, Multicenter, Controlled, Randomized, Evaluator-Blinded Study

Dermatologic Surgery

• Author: Hema Sundaram, MD, FAAD, Ava Shamban, et al.
• Published on December 17, 2021

Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection

Dermatologic Surgery

• Author: Glogau, Richard MD*; Kontis, Theda C. MD†
• Published on August 16, 2021

Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program

Dermatologic Surgery

• Author: Cohen, Joel L. et al.
• Published on February 8, 2021

Advanced Concepts in Rheology for the Evaluation of Hyaluronic Acid–Based Soft Tissue Fillers

Dermatologic Surgery

• Author: Faivre, Jimmy et al.
• Published on January 21, 2021

Learn More About Cervical Dystonia with Dr. Joseph Jankovic

DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA.

Revance Announces Top-Line Results for ASPEN-1

DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA.